In this context, our study focused on the immunohistochemical expression of FOLR1 and FOLR2 in gastric cancer patients, aiming to elucidate their roles in the disease's pathogenesis and potential as prognostic markers or therapeutic targets [12]. Here, FOLR2 is linked to gastric cancer.